← Back to Search

iParent2Parent Support Program for Kidney Transplant Parents

N/A

Recruiting

Led By Samantha J. Anthony, PhD, MSW

Research Sponsored by The Hospital for Sick Children

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to program completion, an average of one year

Awards & highlights

Study Summary

This trial will connect parents of pediatric kidney transplant recipients to offer peer support and mentorship, improving mental health & long-term patient health.

Who is the study for?

This trial is for parents of children under 18 who had a kidney transplant at least two months ago, or under 21 if they're one year post-transplant. They need to speak English and have access to WhatsApp on a device. To be mentors, they must be recommended by their child's healthcare team.Check my eligibility

What is being tested?

The iParent2Parent (iP2P) program is being tested. It's an online mentorship where parents of pediatric kidney transplant recipients give each other support. Participants are randomly chosen to either join iP2P or a control group without this peer support.See study design

What are the potential side effects?

Since the intervention involves social support and not medical treatment, there aren't typical side effects like with drugs or surgery. However, participants may experience emotional impacts from sharing experiences.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to program completion, an average of one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to program completion, an average of one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to program completion, an average of one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability (Mentees)

Acceptability (Mentors)

Adherence with the iParent2Parent program

+5 more

Secondary outcome measures

Coping (Mentees and Mentors)

Family Functioning (Mentees and Mentors)

Parenting stress (Mentees and Mentors)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iParent2Parent ProgramExperimental Treatment1 Intervention

Group II: Standard of Care Waitlist Control GroupActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

iParent2Parent Program

2019

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor

690 Previous Clinical Trials

6,945,423 Total Patients Enrolled

Samantha J. Anthony, PhD, MSWPrincipal InvestigatorThe Hospital for Sick Children

1 Previous Clinical Trials

55 Total Patients Enrolled

Media Library

iParent2Parent Program Clinical Trial Eligibility Overview. Trial Name: NCT05968833 — N/A

Kidney Transplant Research Study Groups: iParent2Parent Program, Standard of Care Waitlist Control Group

Kidney Transplant Clinical Trial 2023: iParent2Parent Program Highlights & Side Effects. Trial Name: NCT05968833 — N/A

iParent2Parent Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05968833 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an upper age limitation for participants of this experiment?

"As the eligibility requirements dictate, prospective participants must be between 18 and 75 years old. For minors or those over 65, there are 7 trials for the former group and 67 clinical studies catered to seniors."

Answered by AI

Am I eligible to join this research project?

"To be accepted to this medical trial, patients must have previously undergone a kidney transplant and fit the age bracket of 18-75 years old. A total of 55 individuals are required for enrolment in the study."

Answered by AI

Are there still openings available for participants of this research?

"The information provided by clinicaltrials.gov indicates that this medical study, which was initially posted on August 1st 2023 and last updated on July 28th 2023 is no longer recruiting patients. Nevertheless, there are other 75 trials currently looking for participants to join in their research."

Answered by AI

What is the primary purpose of this clinical research?

"This clinical trial will last approximately one year, and aims to measure the efficacy of iParent2Parent in terms of adherence. Psychological distress (Mentees & Mentors) is evaluated by administering a 8-item Personal Health Questionnaire Depression Scale; 0-3 scoring system. Perceived social support (Mentees & Mentors) uses Short Form Version 2.0 PROMIS battery with 6 items scored 1-5 resulting in T scores for evaluation. Finally, Coping (Mentees & Mentors) utilises a 16 item questionnaire measuring coping behaviour from 0 - 3 plus “Did not use” responses resulting"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

iParent2Parent Peer Support Program for Parents of Pediatric Kidney Transplant Recipients

Samantha Anthony 2023. "iParent2Parent Peer Support Program for Parents of Pediatric Kidney Transplant Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05968833.

All > Kidney Transplant